Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
OTC Cold Medications and Warfarin: What You Must Avoid to Stay Safe
Mar, 12 2026
Compare Prednisolone with Alternatives: What Works Best for Inflammation and Autoimmune Conditions
Oct, 29 2025
Switching Medications: Proven Strategies to Reduce Side Effects and Avoid Withdrawal
Jan, 31 2026
Noni: Unlocking Polynesian Secrets for Health and Wellness
May, 9 2024
Mesterolone vs Alternatives: Detailed Comparison Guide
Oct, 4 2025